EX-99.1 2 ex99-1.htm REPORT OF VOTING RESULTS ex99-1.htm
Exhibit 99.1

 
BIOVAIL CORPORATION
 
ANNUAL AND SPECIAL MEETING OF SHAREHOLDERS
 
MAY 28, 2009
 
Report of Voting Results
 
National Instrument 51-102 – Continuous Disclosure Obligations
Section 11.3
 
Resolution #1:
 
On a vote by ballot, the shareholders approved the election of Biovail Corporation’s (“Biovail”)  Management director nominees to hold office until the close of the next annual meeting or until their successors are appointed or elected, as follows:
 
MANAGEMENT DIRECTOR NOMINEES
NUMBER OF
VOTES IN
FAVOUR
NUMBER OF
VOTES
WITHHELD
PERCENTAGE
OF VOTES IN
FAVOUR
PERCENTAGE
OF VOTES IN
WITHHELD
Dr. Douglas J.P. Squires
109,631,506
871,121
99.21%
0.79%
Mr. Serge Gouin
109,727,255
775,372
99.30%
0.70%
Mr. David H. Laidley
109,772,521
730,106
99.34%
0.66%
Mr. J. Spencer Lanthier
108,272,513
2,230,114
97.98%
2.02%
Mr. Mark Parrish
108,627,039
1,875,588
98.30%
1.70%
Dr. Laurence E. Paul
108,214,684
2,287,943
97.93%
2.07%
Mr. Robert N. Power
108,625,462
1,877,165
98.30%
1.70%
Mr. Lloyd M. Segal
109,762,403
740,224
99.33%
0.67%
Sir Louis R. Tull
109,613,789
888,838
99.20%
0.80%
Mr. Michael R. Van Every
109,511,887
990,740
99.10%
0.90%
Mr. William Wells
109,776,021
726,606
99.34%
0.66%
 
 
 
 
 
 
 
Resolution #2:
 
On a show of hands, the Chairman declared that the shareholders approved the reappointment of Ernst & Young LLP as auditors to hold office until the close of the next annual meeting and the authorization of the Board of Directors of Biovail to fix the remuneration of the auditors.
 
Resolution #3:
 
On a vote by ballot, the shareholders approved the resolution to amend Biovail’s By-law to (i) reduce the quorum requirement for meetings of shareholders of Biovail; and (ii) eliminate the Chairman’s casting vote at meetings of the Board of Directors, in the form of Schedule 2 to the Management Proxy Circular of Biovail dated April 21, 2009, as follows:
 
 
NUMBER OF VOTES IN FAVOUR:
103,186,556
     
 
PERCENTAGE OF VOTES IN FAVOUR:
93.4%
     
     
 
NUMBER OF VOTES AGAINST:
7,275,762
     
 
PERCENTAGE OF VOTES AGAINST:
6.6%
 
Resolution #4:
 
On a vote by ballot, the shareholders approved the resolution to amend Biovail’s 2007 Equity Compensation Plan (the “Plan”) to (i) increase the number of common shares issuable from treasury pursuant to the Plan; and (ii) increase the percentage of common shares that can be issued upon vesting of restricted share units pursuant to the Plan, in the form of Schedule 3 to the Management Proxy Circular of Biovail dated April 21, 2009, as follows:

 
NUMBER OF VOTES IN FAVOUR:
104,660,234
     
 
PERCENTAGE OF VOTES IN FAVOUR:
94.6%
     
     
 
NUMBER OF VOTES AGAINST:
5,914,260
     
 
PERCENTAGE OF VOTES AGAINST:
5.4%